Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering AG to commence phase I clinical study with Oncolym

June 27, 2000

Promycin clinical studies put on hold

June 27, 2000

Marimastat does not meet primary or secondary endpoints in brain cancer trial

June 26, 2000

Potent tricyclic protein farnesyltransferase inhibitors described by Schering-Plough

June 26, 2000

Collaboration to develop CpG DNA-based cancer products

June 26, 2000

Mechanism of apoptosis induction elucidated for NIK-333

June 23, 2000

Daiichi commences development of new anticancer compound

June 23, 2000

New research strengthens link between COX-2 and angiogenesis/tumor growth

June 23, 2000

New guanidino distamycin analogue selected by Pharmacia for clinical development

June 22, 2000

Halimide: a new cytotoxic alkaloid discovered at the University of California

June 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...